About US
Contact us
-
Bayer's Nexavar in FDA fast lane for thyroid cancer useBayer'sNexavaris one big step closer to athyroid-cancerapproval. The FDA put the drug on the priority-review fast track, which means Nexavar could have its new indication by February. It's a timely wi2013/8/28
-
Fierce welcomes newest publication: FierceDiagnosticsThree years ago, we answered the need for more coverage in the medtech space with the launch ofFierceMedicalDevices. Now one of our top publications, it is proving to be an incredible success. And now2013/8/27
-
Sanofi eyes superiority claim for Fluzone High-Dose after trial boostSanofi's ($SNY) high-dose formulation ofFluzonescored in a new trial in seniors. The study pitted Fluzone High-Dose against the regular formula and found that the amped-up version offered 24% better p2013/8/27
-
Lilly investigating allegations of $4.9M in Chinese bribesEli Lilly ($LLY), the most recent company targeted with bribery accusations inChina, is looking into the matter itself. The company says it is "deeply concerned" by allegations that ran Thursday in a2013/8/26
-
FDA says Mylan's Wellbutrin generic stacks up to branded drugMylan ($MYL) is the first drugmaker to make it through FDA scrutiny of its generic of antidepressantWellbutrin XLin a regulatory episode that has reignited debate over the quality ofgenericsversus bra2013/8/26
-
Indian authorities confirm closer look at Ranbaxy operationsQuestions continue to brew in home country months after drugmaker settled with U.S. authorities In the U.S., the furor overRanbaxy Laboratories' misdeeds has largely settled down, but the generics dr2013/8/26
-
Whistleblower: Lilly spent $4.9M bribing Chinese docs to prescribe diabetes medsAnother Chinesewhistleblowerhas targeted Big Pharma. This time, the bribery allegations involve Eli Lilly ($LLY), and 30 million yuan in purported kickbacks to Chinese doctors. That's about $4.9 milli2013/8/23
-
CFDA Minister Zhang Yong meets Czech Health MinisterOn the afternoon of August 20, 2013, Zhang Yong, Minister of China Food and Drug Administration (CFDA), met with the delegation led by Mr. Martin Holcát, Minister of Health of the Czech Republic2013/8/23
-
CFDA Vice Minister Yin Li meets Swiss Federal Councillor and the Ambassador of Switzerland to ChinaOn the morning of August 16, 2013, Yin Li, Vice Minister of China Food and Drug Administration (CFDA) met with the delegation led by Mr. Alain Berset, Swiss Federal Councillor and Head of the Swiss Fe2013/8/22
-
Bayer's Stivarga nabs new approval in newly popular JapanBayer's cancer drugStivargahas racked up another approval. Japanese regulators cleared thecolon cancertreatment for a new use, against gastrointestinal stromal tumors. It's just the latest victory for2013/8/21